Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

v3.20.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings (Accumulated Deficit)
Noncontrolling Interest
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018   19,204,000      
Beginning balance at Dec. 31, 2018 $ 120,568 $ 133,684 $ (2,072) $ 63 $ (11,107)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 230 $ 230      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   69,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (189) $ (189)      
Net income (loss) 1,729   1,757 (28)  
Other comprehensive loss (316)       (316)
Ending balance (in shares) at Mar. 31, 2019   19,273,000      
Ending balance at Mar. 31, 2019 $ 122,022 $ 133,725 (315) 35 (11,423)
Beginning balance (in shares) at Dec. 31, 2019 19,410,000 19,410,000      
Beginning balance at Dec. 31, 2019 $ 129,436 $ 135,741 4,693 227 (11,225)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 394 $ 394      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   60,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (159) $ (159)      
Net income (loss) 3,006   2,962 44  
Other comprehensive loss $ (109)       (109)
Ending balance (in shares) at Mar. 31, 2020 19,470,000 19,470,000      
Ending balance at Mar. 31, 2020 $ 132,568 $ 135,976 $ 7,655 $ 271 $ (11,334)